InBios International

InBios International is a Seattle-based biotechnology company that develops, manufactures and sells rapid tests and ELISA-based immunodiagnostic kits for infectious diseases. Its products target tropical and emerging pathogens such as dengue, Zika, chikungunya, West Nile, Chagas, leishmaniasis and COVID-19. Its Active Detect rapid tests and DPP-based assays serve public health, clinical and research customers worldwide.